Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study
M.J. Millward, B.M.J. Cantwell, N.C. Munro et al. · British Journal of Cancer · 1993
Cited by 91 works. doi:10.1038/bjc.1993.189
Authors
References
- Expression of a multidrug-resistance gene in human tumors and tissues.
- Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
- Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?
- MDR1 Gene Expression in Lung Cancer
- Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.
- P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.
- A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer
- Neurotoxicity of antineoplastic drugs.
- Chemotherapy in advanced non-small cell lung cancer